CLOVER HEALTH INVESTMENTS, CORP. /DE

By person

26 insiders · 59 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

Palihapitiya Chamath

10% owner

$10.00M (1)

—

+$10.00M

42,239,130

$199.37M

+45.6%

Wai Conrad

CEO, Counterpart Health

—

$3.10M (5) scheduled

−$3.10M

3,625,811

$17.11M

−25.1%

Garipalli Vivek

Director

$3.00M (4)

—

+$3.00M

3,534,120

$16.68M

—

Toy Andrew

Chief Executive Officer

—

$2.37M (3) scheduled

−$2.37M

9,459,316

$44.65M

—

Priest Brady Patrick

CEO of Clover Care Services

—

$1.00M (3)

−$1.00M

2,040,222

$9.63M

+1,341%

Edwards Carladenise Armbrister

Director

—

$951.69K (2)

−$951.69K

285,432

$1.35M

—

Reynoso Jamie L.

CEO, Medicare Advantage

—

$597.63K (20) scheduled

−$597.63K

2,805,367

$13.24M

—

Soares Karen

Chief Legal Officer

—

$536.09K (5) scheduled

−$536.09K

1,607,371

$7.59M

+155.0%

Clinton Chelsea

Director

$252.53K (1)

—

+$252.53K

602,814

$2.85M

—

SHAPIRO LEE

Director

$248.07K (1)

—

+$248.07K

598,622

$2.83M

—

Loengard Anna U

Director

$218.68K (10)

—

+$218.68K

557,066

$2.63M

—

OLDAKOWSKI JOSEPH FRANK

VP OF FINANCE AND CONTROLLER

—

$162.02K (2)

−$162.02K

279,067

$1.32M

−10.3%

THORNTON JOSEPH CLAY

Interim CFO

—

$99.65K (2) scheduled

−$99.65K

1,249,526

$5.90M

+0.9%

Osborne Ian

10% owner

—

30,500,000

$143.96M

+510.0%

Kuipers Peter J.

Chief Financial Officer

—

5,758,353

$27.18M

−15.9%

Leffler Scott J.

Chief Financial Officer

—

4,857,303

$22.93M

+48,473%

CLOVER HEALTH INVESTMENTS, CORP. /DE entity

Chief Technology Officer

—

3,093,225

$14.60M

+16.6%

Martin Joseph Richards

General Counsel

—

2,718,857

$12.83M

—

Sharp Aric R

CEO of Value Based Care

—

2,100,665

$9.92M

—

Singh Prabhdeep

Chief Growth Officer

—

872,821

$4.12M

—

Kouzoukas Demetrios L.

Director

—

605,980

$2.86M

—

Robinson William G Jr

Director

—

597,987

$2.82M

—

Reses Jacqueline D

FORMER DIRECTOR

—

300,000

$1.42M

—

Tran Thomas L

Director

—

180,029

$849.74K

+353.6%

Ryans James

FORMER DIRECTOR

—

100,000

$472.00K

—

Wagner Joseph F.

Chief Financial Officer

—

25,000

$118.00K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Insider

Date

Role

Action

Price

Amount

Loengard Anna U

13 Aug 2025

Director

Buy indirect

14,500

$2.59

$37.56K

Loengard Anna U

13 Aug 2025

Director

Buy indirect

12,000

$2.60

$31.20K

Garipalli Vivek

8 Aug 2025

Director

Buy

31,980

$2.17

$69.40K

Garipalli Vivek

7 Aug 2025

Director

Buy

415,000

$2.24

$929.60K

Garipalli Vivek

9 Aug 2024

Director

Buy

531,700

$1.88

$999.60K

Garipalli Vivek

17 Jun 2024

Director

Buy

877,567

$1.14

$1.00M

Loengard Anna U

17 May 2024

Director

Buy indirect

10,000

$0.93

$9.30K

Loengard Anna U

16 May 2024

Director

Buy indirect

1,485

$0.94

$1.40K

Loengard Anna U

16 May 2024

Director

Buy indirect

15,600

$0.96

$14.98K

Loengard Anna U

14 Mar 2024

Director

Buy indirect

13,625

$0.73

$9.95K

Loengard Anna U

14 Mar 2024

Director

Buy

137,000

$0.73

$100.01K

Loengard Anna U

6 Sep 2023

Director

Buy indirect

500

$1.30

$650.00

Loengard Anna U

6 Sep 2023

Director

Buy indirect

500

$1.30

$650.00

Loengard Anna U

6 Sep 2023

Director

Buy indirect

10,000

$1.30

$13.00K

SHAPIRO LEE

11 Mar 2022

Director

Buy

80,000

$3.10

$248.07K

Clinton Chelsea

3 Mar 2022

Director

Buy

100,000

$2.53

$252.53K

Palihapitiya Chamath

22 Nov 2021

10% owner

Buy indirect

1,739,130

$5.75

$10.00M

Show all 59 transactions →

CLOVER HEALTH INVESTMENTS, CORP. /DE

By person

Individual transactions

What was left out